International Flavors & Fragrances (IFF) is on the warpath again, says the Financial Times A year after spending $7.3bn to buy Frutarom Industries as part of its plan “to consolidate the food flavouring sector”, it is splashing out another $26.2bn to buy DuPont’s nutrition and biosciences business. The new company, which will be run by IFF’s CEO, aims to be a “giant” in the flavourings and nutrients industry. It will have an enterprise value of $45bn and annual revenues of $11bn, employing 23,000 people and providing ingredients for “products from vegan burgers to salad dressing to laundry detergent”.
While International Flavors & Fragrances has been expanding through acquisitions, DuPont has been going in the opposite direction as it looks to “salvage shareholder value” in the face of a US-China trade war that has “crimped growth”, says Bloomberg. Even though DuPont merged with Dow only three years ago, the “chemical giant” created by that alliance has already undergone a large degree of fragmentation. Not only was the Dow division spun off earlier this year, but this was followed by the agriculture business, leaving the conglomerate now split into three parts.
A mixture of flavours
Both firms hope that the merger will enable them to “blitz” the global ingredients market while “significantly” cutting down on costs, says Michelle Toh for CNN. Both companies are projecting savings of “about $300m” within three years of closing the deal and expect the new company to achieve a “leading position in segments including soy proteins, enzymes and probiotics”. In particular, they hope to take advantage of the fact that “consumers have been increasingly gravitating toward healthier and more natural flavours”, which accounted for over 50% of the market in 2018.
The two companies could work better together as one, with IFF’s “lab wizardry” and DuPont’s manufacturing know-how encouraging big clients “to buy more natural colourings, emulsifiers and so forth”, says Liam Proud on Breakingviews. Still, it looks as though DuPont’s shareholders are getting the “juiciest morsels”, with a $7.3bn special cash payment as well as “55.4% of the combined business”. The deal will have a “slightly off odour” for IFF, who will not only be swallowing a much larger company at an “expensive valuation”, but also adding a “slug of debt” as well.
The deal is also bad news for Irish firm Kerry, whom IFF pipped to the prize, says The Irish Times. Kerry had hoped that taking over part of DuPont’s business would have helped it “expand in healthy bacteria strains, ingredients found in dietary supplements, cheese and bakery products, and nutritional products that prevent or treat diseases. Having lost out on a deal that would have been one of the biggest carried out by a listed Irish company, the stock has fallen by 4% this week.